Zimmer Biomet Holdings, Inc.
NYSE:ZBHMedical - Devices
+$0.87 today
- Market cap
- $19.55B
- Beta
- 0.47
- P/E (TTM)
- 22.5
- EPS (TTM)
- $3.90
- Dividend yield
- 1.09%
Volume 2.34M
Average 2.28M
ZBH Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Zimmer Biomet Holdings, Inc.NYSE: ZBH
Accumulated OCI · Q2 FY2026 · quarter ended Jun 2026
Accumulated OCI remains negative
Q2 FY2026 Accumulated OCI was -$163.9M, compared with -$284.5M a year earlier.
Context
- Accumulated OCI amounted to 0.7% of total assets at the end of Q2 FY2026, down 0.5 pp from a year earlier.
- Accumulated OCI grew in size in 2 of the last 3 fiscal years.
What to watch
Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +42.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- (205.7M) USD
- Year-over-year change
- +21.7%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (205.7M) | +21.7% |
| FY2024 | 2024-12-31 | (262.8M) | -37.6% |
| FY2023 | 2023-12-31 | (191M) | -6.5% |
| FY2022 | 2022-12-31 | (179.3M) | +22.6% |
| FY2021 | 2021-12-31 | (231.6M) | — |
Accumulated OCI vs competitors
How ZBH compares with its peers on the latest reported figures
- Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +42.4% is the 4th highest of 9, against a peer median of +21.6%.
- Accumulated OCI amounts to 0.7% of total assets for ZBH, versus a peer median of 1.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | €644M EUR | +85.6% | -43.1% | 2.4% | |
| Jun 2026 | $66.59M USD | +8.8% | — | 1.0% | |
| Dec 2025 | $20M USD | — | — | 0.2% | |
| Mar 2026 | $142K USD | +105.6% | — | 0.0% | |
| Jun 2026 | -$163.9M USD | +42.4% | — | 0.7% | |
| Jun 2026 | -$214.6M USD | +18.7% | — | 1.5% | |
| Jun 2026 | -$304M USD | +57.9% | — | 0.7% | |
| Jun 2026 | -$576M USD | +24.4% | — | 1.2% | |
| Jun 2026 | -$1.48B USD | -35.8% | — | 4.0% | |
| Jul 2026 | -$3.76B USD | +18.4% | — | 4.0% | |
| Peer median (excluding ZBH) | — | +21.6% | -43.1% | 1.2% | |
Competitors are the stored peer set for ZBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 378.1M | 375.7M | 415.8M | 525.5M | 591.9M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.26B | 1.38B | 1.44B | 1.48B | 1.7B |
| Inventory | 2.15B | 2.15B | 2.39B | 2.24B | 2.29B |
| Other Current Assets | 772.6M | 324.5M | 366.1M | 430M | 537.2M |
| Total Current Assets | 4.89B | 4.43B | 4.61B | 4.67B | 5.12B |
| Property, Plant & Equipment (Net) | 1.84B | 1.87B | 2.06B | 2.05B | 2.21B |
| Goodwill | 8.92B | 8.58B | 8.82B | 8.95B | 9.95B |
| Intangible Assets | 5.53B | 5.06B | 4.86B | 4.6B | 4.72B |
| Long-term Investments | 27.6M | 16.6M | 31.6M | 73.2M | 39.4M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 2.25B | 1.11B | 1.12B | 1.02B | 1.1B |
| Total Non-current Assets | 18.57B | 16.64B | 16.89B | 16.69B | 17.97B |
| Total Assets | 23.46B | 21.07B | 21.5B | 21.37B | 23.09B |
| Account Payables | 306.5M | 354.1M | 410.6M | 194.6M | 303M |
| Short-term Debt | 1.61B | 544.3M | 900M | 863M | 587.1M |
| Tax Payables | 62M | 38.5M | 61.2M | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 640.5M | 502.8M | 326.1M | 286M | 382M |
| Total Current Liabilities | 3.47B | 2.36B | 2.86B | 2.45B | 2.58B |
| Long-term Debt | 5.46B | 5.15B | 4.87B | 5.34B | 6.93B |
| Deferred Tax Liabilities | 558.5M | 474.8M | 357.6M | 352.5M | 244.1M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.3B | 1.05B | 925.9M | 744.1M | 626.1M |
| Total Non-current Liabilities | 7.32B | 6.68B | 6.15B | 6.44B | 7.8B |
| Total Liabilities | 10.79B | 9.04B | 9.01B | 8.89B | 10.39B |
| Common Stock | 3.1M | 3.1M | 3.2M | 3.2M | 3.2M |
| Retained Earnings | 10.29B | 9.56B | 10.38B | 11.1B | 11.61B |
| Accumulated OCI | (231.6M) | (179.3M) | (191M) | (262.8M) | (205.7M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 5.7M | 6.7M | 7.7M | 8.1M | 8.1M |
| Total Equity | 12.67B | 12.03B | 12.48B | 12.48B | 12.71B |
| Total Debt | 7.07B | 5.7B | 5.77B | 6.2B | 7.52B |
| Net Debt | 6.69B | 5.32B | 5.35B | 5.68B | 6.93B |
Zimmer Biomet Holdings, Inc.
NYSE:ZBH
Intrinsic Alpha fair value
Locked
Current Price
$103.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.